PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients: a Danish cohort study

MLA

Deirdre Cronin-Fenton, et al. “PD-L1 Expression, EGFR and KRAS Mutations and Survival among Stage III Unresected Non-Small Cell Lung Cancer Patients: A Danish Cohort Study.” Scientific Reports, vol. 11, no. 1, Aug. 2021, pp. 1–9. EBSCOhost, https://doi.org/10.1038/s41598-021-96486-2.

APA

Deirdre Cronin-Fenton, Tapashi Dalvi, Naimisha Movva, Lars Pedersen, Hanh Hansen, Jon Fryzek, Elizabeth Hedgeman, Anders Mellemgaard, Torben R. Rasmussen, Norah Shire, Stephen Hamilton-Dutoit, & Mette Nørgaard. (2021). PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients: a Danish cohort study. Scientific Reports, 11(1), 1–9. https://doi.org/10.1038/s41598-021-96486-2

Chicago

Deirdre Cronin-Fenton, Tapashi Dalvi, Naimisha Movva, Lars Pedersen, Hanh Hansen, Jon Fryzek, Elizabeth Hedgeman, et al. 2021. “PD-L1 Expression, EGFR and KRAS Mutations and Survival among Stage III Unresected Non-Small Cell Lung Cancer Patients: A Danish Cohort Study.” Scientific Reports 11 (1): 1–9. doi:10.1038/s41598-021-96486-2.